Cargando…
Understanding MCL1: from cellular function and regulation to pharmacological inhibition
Myeloid cell leukemia‐1 (MCL1), an antiapoptotic member of the BCL2 family characterized by a short half‐life, functions as a rapid sensor that regulates cell death and other relevant processes that include cell cycle progression and mitochondrial homeostasis. In cancer, MCL1 overexpression contribu...
Autores principales: | Sancho, Mónica, Leiva, Diego, Lucendo, Estefanía, Orzáez, Mar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787394/ https://www.ncbi.nlm.nih.gov/pubmed/34310025 http://dx.doi.org/10.1111/febs.16136 |
Ejemplares similares
-
BOK-MCL1 transmembrane interactions: a challenging target for cancer therapy
por: Sancho, Mónica, et al.
Publicado: (2021) -
The pharmacological management of depression
por: Kupfer, David J.
Publicado: (2005) -
Pharmacological approaches to the challenge of treatment-resistant depression
por: Ionescu, Dawn F., et al.
Publicado: (2015) -
The intersection of pharmacology, imaging, and genetics in the development of personalized medicine
por: Gerretsen, Philip, et al.
Publicado: (2009) -
Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy
por: Kim, Hee-Je, et al.
Publicado: (2021)